Showing results (31-40 of 174) with videos related to

Sort By:
Pageof 18
Annals of Hematology|April 28, 2006
Rituximab long-term maintenance therapy after autologous stem cell transplantation in patients with B-cell non-Hodgkin's lymphomaFrank Neumann, Stefani Harmsen, Simona Martin, et al.
Expert Review of Anticancer Therapy|July 24, 2020
Improving the accuracy of prognostication in chronic myelomonocytic leukemiaJennifer Kaivers, Esther Schuler, Barbara Hildebrandt, et al.
Cancer|June 15, 2007
Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypesSabine Knipp, Barbara Hildebrand, Andrea Kündgen, et al.
Nuclear Medicine and Biology|November 26, 2008
cis-4-[(18)F]-Fluoro-l-proline fails to detect peripheral tumors in humansGabriele Stoffels, Dirk Pauleit, Rainer Haas, et al.
Annals of Hematology|May 6, 2017
A retrospective study evaluating the impact of infectious complications during azacitidine treatmentAnna Schuck, Marie-Christine Goette, Judith Neukirchen, et al.
Cancer|July 27, 2017
Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosisJudith Neukirchen, Michael Lauseker, Barbara Hildebrandt, et al.
Leukemia & Lymphoma|December 11, 2007
Escalation therapy with bortezomib, dexamethasone and bendamustine for patients with relapsed or refractory multiple myelomaRoland Fenk, Mark Michael, Fabian Zohren, et al.
Leukemia & Lymphoma|June 11, 2011
Predictive factors for successful salvage high-dose therapy in patients with multiple myeloma relapsing after autologous blood stem cell transplantationRoland Fenk, Vanessa Liese, Florian Neubauer, et al.
European Journal of Haematology|May 14, 2021
Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1-mRNA expression in patients with AML and MDSChristina Rautenberg, Michael Lauseker, Jennifer Kaivers, et al.
Leukemia Research|May 2, 2015
Change of prognosis of patients with myelodysplastic syndromes during the last 30 yearsJudith Neukirchen, Kathrin Nachtkamp, Jennifer Schemenau, et al.
Pageof 18